Patient Monitoring Device/System/Equipment Market expected to reach USD 25.31 Billion by 2023, at a CAGR of 5.7%, over 2017–2023
The patient monitoring devices market is expected to reach USD 25.31 billion by 2023 from USD 19.14 billion in 2018, at a CAGR of 5.7%. Factors such as the easy availability of wireless monitoring devices and the rising incidence of lifestyle and chronic diseases are expected to drive market growth during the forecast period. On the other hand, the risks associated with invasive monitoring devices...
Favorable Regulations Driving the Use of Biological Safety Cabinets in the Healthcare Industry
The biological safety cabinets market is projected to reach USD 205.9 million by 2022 from USD 144.3 million in 2017, at a CAGR of 7.4% during the forecast period.
Growth in the biological safety cabinets market is mainly driven by factors such as favorable regulations, increased risk of pandemics and communicable diseases, increasing number of R&D activities in biotechnological and pharmaceutical...
Specimen Validity Testing Market is Primarily Driven by The Growth in Drug Screening Market And Increase in Workplace Drug Testing
The global specimen validity testing market is projected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%. The growth of the specimen validity testing market is primarily driven by the growth in the drug screening market and increase in workplace drug testing.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=147024121
The specimen validity...
Neuroscience Antibodies & Assays Market : Rising Incidence of Neurological Diseases
The global neuroscience antibodies and assays market is expected to reach USD 4.18 billion by 2023 from USD 2.57 billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. On the other hand, quality and cost concerns over the production...
Immunoassay Market | Increasing Adoption of Immunoassay-Based Point-Of-Care Testing and Rapid Testing
The immunoassays market is expected to reach USD 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1%. Factors driving the growth of this market include the increasing adoption of immunoassay-based point-of-care (POC) testing and rising incidence of chronic diseases across the world.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=436
The global immunoassays...
Biomarker Technologies Market : Increasing Utility of Biomarkers for Diagnostic Purposes And Rising Biomarker Research
The global biomarker technologies market was valued at USD 46.97 billion in 2017. It is expected to reach USD 74.51 billion in 2022, at CAGR of 9.7% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=190358765
The growth of this market is mainly driven by increasing healthcare expenditure, rising R&D funding, the increasing utility of biomarkers...
Significant Opportunities for the Growth of Oncology-Based Nutrition Formulas.
The global oncology nutrition market is projected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. Factors such shift from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rise in number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional...
Opportunities of Medical Device Connectivity Market in Healthcare Industry
The global medical device connectivity market is projected to reach USD 2,670.3 million by 2023 from USD 939.4 million in 2018, at a CAGR of 23.2%. Growth in this market can be attributed to a number of factors such as the increasing penetration of EHRs & health information exchange systems in healthcare organizations, healthcare IT initiatives driving the integration of medical devices with hospital...
Growing Adoption of Open Innovation Models Dominating High Throughput Screening Market
The global high-throughput screening (HTS) market is projected to reach USD 21.69 billion by 2023 from USD 14.87 billion in 2018, at a CAGR of 7.8%. Factors such initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments are driving the growth of the...
Growing Prevalence of Animal Diseases Causing Pain and Inflammation Driving Veterinary Pain Management Market
The veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and rising adoption...